Enterix, Inc. recalls InSure ONE Fecal Immunochemical Test. Labeled as follows: 1. Insure ONE POL…
Insure ONE POL Patient Kit - 10 pack.
Enterix, Inc. began a medical device recall on September 17, 2025 whose reported distribution included Ohio. FDA
What the record shows
recalled InSure ONE Fecal Immunochemical Test. Labeled as follows: 1. Model Number: 90010. 2. Insure ONE POL Patient Kit … beginning September 17, 2025, in a medical device recall whose distribution included Ohio. The stated reason: InSure ONE failed sensitivity testing when used with Test Card Lot T241102, which may result in false negative results. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 201,426 test kits. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: September 17, 2025 FDA
- Recall number: Z-0725-2026 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Enterix, Inc. FDA
- Product: InSure ONE Fecal Immunochemical Test. Labeled as follows: 1. Insure ONE POL Patient Kit - 10 pack. Model Number… FDA
- Reason for recall: InSure ONE failed sensitivity testing when used with Test Card Lot T241102, which may result in false negative results. FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | Z-0725-2026 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Enterix, Inc. |
| Product | InSure ONE Fecal Immunochemical Test. Labeled as follows: 1. Insure ONE POL Patient Kit - 10 pack. Model Number: 90010. 2. Insure ONE POL Patient Kit - 25 Pack. Model Number: 90025. 3. InSure ONE POL Combo Pack. Model Number: 90030. InSure ONE is a fecal immunochemical test (FIT) that qualitatively detects human hemoglobin from blood in fecal samples. |
| Reason for recall | InSure ONE failed sensitivity testing when used with Test Card Lot T241102, which may result in false negative results. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | medical device |
| Quantity | 201,426 test kits |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20250917 |
| Reported | 20251210 |
| Distribution | Worldwide - US Nationwide distribution in the states of California, Florida, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Nevada, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Texas, Washington, West Virginia and the country of Philippines. |
| Firm location | Edison, NJ, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.